These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34622799)

  • 1. Hypomorphic ASGR1 modulates lipid homeostasis via INSIG1-mediated SREBP signaling suppression.
    Xu Y; Tao J; Yu X; Wu Y; Chen Y; You K; Zhang J; Getachew A; Pan T; Zhuang Y; Yuan F; Yang F; Lin X; Li YX
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34622799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asialoglycoprotein receptor 1 is a novel PCSK9-independent ligand of liver LDLR cleaved by furin.
    Susan-Resiga D; Girard E; Essalmani R; Roubtsova A; Marcinkiewicz J; Derbali RM; Evagelidis A; Byun JH; Lebeau PF; Austin RC; Seidah NG
    J Biol Chem; 2021 Oct; 297(4):101177. PubMed ID: 34508778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of sterol-response element-binding proteins (SREBP) in alveolar type II cells enhances lipogenesis causing pulmonary lipotoxicity.
    Plantier L; Besnard V; Xu Y; Ikegami M; Wert SE; Hunt AN; Postle AD; Whitsett JA
    J Biol Chem; 2012 Mar; 287(13):10099-10114. PubMed ID: 22267724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia.
    Ng R; Wu H; Xiao H; Chen X; Willenbring H; Steer CJ; Song G
    Hepatology; 2014 Aug; 60(2):554-64. PubMed ID: 24677249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent effects of siRNA-mediated inhibition of SCAP on PCSK9, LDLR, and plasma lipids in mouse and rhesus monkey.
    Jensen KK; Tadin-Strapps M; Wang SP; Hubert J; Kan Y; Ma Y; McLaren DG; Previs SF; Herath KB; Mahsut A; Liaw A; Wang S; Stout SJ; Keohan C; Forrest G; Coelho D; Yendluri S; Williams S; Koser M; Bartz S; Akinsanya KO; Pinto S
    J Lipid Res; 2016 Dec; 57(12):2150-2162. PubMed ID: 27707816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNA-mediated inhibition of SREBP cleavage-activating protein reduces dyslipidemia in spontaneously dysmetabolic rhesus monkeys.
    Murphy BA; Tadin-Strapps M; Jensen K; Mogg R; Liaw A; Herath K; Bhat G; McLaren DG; Previs SF; Pinto S
    Metabolism; 2017 Jun; 71():202-212. PubMed ID: 28521874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.
    Guérin M; Le Goff W; Lassel TS; Van Tol A; Steiner G; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):282-8. PubMed ID: 11156866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASGR1 Deficiency Inhibits Atherosclerosis in Western Diet-Fed
    Zhang Y; Jiang X; Wang W; Lei L; Sheng R; Li S; Luo J; Liu H; Zhang J; Han X; Li Y; Zhang Y; Wang C; Si S; Jin ZG; Xu Y
    Arterioscler Thromb Vasc Biol; 2024 Dec; 44(12):2428-2449. PubMed ID: 39387120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LH Induces De Novo Cholesterol Biosynthesis via SREBP Activation in Granulosa Cells During Ovulation in Female Mice.
    Nakanishi T; Tanaka R; Tonai S; Lee JY; Yamaoka M; Kawai T; Okamoto A; Shimada M; Yamashita Y
    Endocrinology; 2021 Nov; 162(11):. PubMed ID: 34431998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
    Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
    Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New CETP inhibitor K-312 reduces PCSK9 expression: a potential effect on LDL cholesterol metabolism.
    Miyosawa K; Watanabe Y; Murakami K; Murakami T; Shibata H; Iwashita M; Yamazaki H; Yamazaki K; Ohgiya T; Shibuya K; Mizuno K; Tanabe S; Singh SA; Aikawa M
    Am J Physiol Endocrinol Metab; 2015 Jul; 309(2):E177-90. PubMed ID: 26015437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.
    Urban D; Pöss J; Böhm M; Laufs U
    J Am Coll Cardiol; 2013 Oct; 62(16):1401-8. PubMed ID: 23973703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAQR3 modulates cholesterol homeostasis by anchoring Scap/SREBP complex to the Golgi apparatus.
    Xu D; Wang Z; Zhang Y; Jiang W; Pan Y; Song BL; Chen Y
    Nat Commun; 2015 Aug; 6():8100. PubMed ID: 26311497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genes.
    Zhang L; McCabe T; Condra JH; Ni YG; Peterson LB; Wang W; Strack AM; Wang F; Pandit S; Hammond H; Wood D; Lewis D; Rosa R; Mendoza V; Cumiskey AM; Johns DG; Hansen BC; Shen X; Geoghagen N; Jensen K; Zhu L; Wietecha K; Wisniewski D; Huang L; Zhao JZ; Ernst R; Hampton R; Haytko P; Ansbro F; Chilewski S; Chin J; Mitnaul LJ; Pellacani A; Sparrow CP; An Z; Strohl W; Hubbard B; Plump AS; Blom D; Sitlani A
    Int J Biol Sci; 2012; 8(3):310-27. PubMed ID: 22355267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced VLDL clearance in Apoe(-/-)Npc1(-/-) mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels.
    Ishibashi M; Masson D; Westerterp M; Wang N; Sayers S; Li R; Welch CL; Tall AR
    J Lipid Res; 2010 Sep; 51(9):2655-63. PubMed ID: 20562239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aloe-emodin exerts cholesterol-lowering effects by inhibiting proprotein convertase subtilisin/kexin type 9 in hyperlipidemic rats.
    Su ZL; Hang PZ; Hu J; Zheng YY; Sun HQ; Guo J; Liu KY; Du ZM
    Acta Pharmacol Sin; 2020 Aug; 41(8):1085-1092. PubMed ID: 32203084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sterol metabolism and SREBP activation.
    Sato R
    Arch Biochem Biophys; 2010 Sep; 501(2):177-81. PubMed ID: 20541520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat Shock Protein 90 Modulates Lipid Homeostasis by Regulating the Stability and Function of Sterol Regulatory Element-binding Protein (SREBP) and SREBP Cleavage-activating Protein.
    Kuan YC; Hashidume T; Shibata T; Uchida K; Shimizu M; Inoue J; Sato R
    J Biol Chem; 2017 Feb; 292(7):3016-3028. PubMed ID: 28003358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterohepatic Transcription Factor CREB3L3 Protects Atherosclerosis via SREBP Competitive Inhibition.
    Nakagawa Y; Wang Y; Han SI; Okuda K; Oishi A; Yagishita Y; Kumagai K; Ohno H; Osaki Y; Mizunoe Y; Araki M; Murayama Y; Iwasaki H; Konishi M; Itoh N; Matsuzaka T; Sone H; Yamada N; Shimano H
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):949-971. PubMed ID: 33246135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of estrogen receptor α (ERα) is required for Alisol B23-acetate to prevent post-menopausal atherosclerosis and reduced lipid accumulation.
    Chen Q; Chao Y; Zhang W; Zhang Y; Bi Y; Fu Y; Cai D; Meng Q; Li Y; Bian H
    Life Sci; 2020 Oct; 258():118030. PubMed ID: 32739470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.